https://www.uclahealth.org/news/release/nih-grant-awarded-physician-scientist-develop-novel-ways
The National Institutes of Health has awarded Dr. Steven Jonas with a five-year $1.25 million grant through its High-Risk, High-Reward Research Program.
nih grantphysician scientistawardeddevelopnovel
https://www.pharmaceutical-technology.com/data-insights/iti-1284-intra-cellular-therapies-net-present-value-2/
ITI-1284 is a small molecule commercialized by Intra-Cellular Therapies, with a leading Phase II program in Psychosis;Generalized Anxiety Disorder (GAD).
net present valuerisk adjustedcurrentvaluation
https://www.uab.cat/web/estudiar/official-master-s-degrees/teaching-staff-1096480963107.html?param1=1345831670776
Online training in transfusion medicine and cellular and tissue therapies 100% in English or bilingual Spanish-English to practise professionally...
teaching stafftransfusion medicineofficialmasterdegree
https://www.pharmaceutical-technology.com/data-insights/long-acting-injectable-program-intra-cellular-therapies-schizoaffective-disorder-likelihood-of-approval/
Long-Acting Injectable Program is under clinical development by Intra-Cellular Therapies and currently in Phase I for Schizoaffective Disorder.
long actingcellular therapiesinjectableprogramintra
https://www.biospace.com/intra-cellular-therapies-to-present-at-the-45th-annual-goldman-sachs-global-healthcare-conference
Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous...
cellular therapiesintrapresentannualgoldman